WVE
Income statement / Annual
Last year (2024), Wave Life Sciences Ltd.'s total revenue was $108.30 M,
a decrease of 4.42% from the previous year.
In 2024, Wave Life Sciences Ltd.'s net income was -$97.01 M.
See Wave Life Sciences Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$108.30 M |
$113.31 M |
$3.65 M |
$40.96 M |
$20.08 M |
$15.98 M |
$14.41 M |
$3.70 M |
$1.49 M |
$152,000.00 |
| Cost of Revenue |
$8.66 M
|
$9.21 M
|
$10.11 M
|
$121.88 M
|
$124.17 M
|
$175.43 M
|
$134.43 M
|
$79.31 M
|
$393,000.00
|
$9.06 M
|
| Gross Profit |
$99.64 M
|
$104.10 M
|
-$6.47 M
|
-$80.91 M
|
-$104.09 M
|
-$159.45 M
|
-$120.01 M
|
-$75.61 M
|
$1.09 M
|
-$8.91 M
|
| Gross Profit Ratio |
0.92
|
0.92
|
-1.77
|
-1.98
|
-5.18
|
-9.98
|
-8.33
|
-20.41
|
0.74
|
-58.59
|
| Research and Development Expenses |
$159.68 M
|
$130.01 M
|
$115.86 M
|
$121.88 M
|
$130.94 M
|
$175.43 M
|
$134.43 M
|
$79.31 M
|
$40.82 M
|
$9.06 M
|
| General & Administrative Expenses |
$59.02 M
|
$51.29 M
|
$50.51 M
|
$46.11 M
|
$42.51 M
|
$48.87 M
|
$39.51 M
|
$26.98 M
|
$15.99 M
|
$10.39 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$59.02 M
|
$51.29 M
|
$50.51 M
|
$46.11 M
|
$42.51 M
|
$48.87 M
|
$39.51 M
|
$26.98 M
|
$15.99 M
|
$10.39 M
|
| Other Expenses |
$0.00
|
$0.00
|
$7,000.00
|
$4.54 M
|
$2.06 M
|
$9.74 M
|
$9.55 M
|
-$331,000.00
|
-$50,000.00
|
$56,000.00
|
| Operating Expenses |
$218.71 M
|
$181.30 M
|
$166.37 M
|
$167.98 M
|
$173.45 M
|
$224.30 M
|
$173.94 M
|
$106.28 M
|
$56.81 M
|
$19.45 M
|
| Cost And Expenses |
$218.71 M
|
$181.30 M
|
$166.37 M
|
$167.98 M
|
$173.45 M
|
$224.30 M
|
$173.94 M
|
$106.28 M
|
$56.81 M
|
$19.45 M
|
| Interest Income |
$0.00
|
$7.93 M
|
$0.00
|
$30,000.00
|
$568,000.00
|
$4.94 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$16,000.00
|
$0.00
|
$22,000.00
|
$6,000.00
|
$337,000.00
|
$86,000.00
|
| Depreciation & Amortization |
$8.66 M
|
$9.21 M
|
$10.11 M
|
$9.84 M
|
$9.98 M
|
$9.20 M
|
$5.58 M
|
$2.16 M
|
$784,000.00
|
$594,000.00
|
| EBITDA |
-$101.74 M |
-$58.79 M |
-$152.61 M |
-$117.18 M |
-$143.39 M |
-$200.73 M |
-$153.94 M |
-$100.24 M |
-$54.94 M |
-$18.56 M |
| EBITDA Ratio |
-0.94
|
-0.52
|
-41.82
|
-2.86
|
-7.14
|
-12.56
|
-10.68
|
-27.06
|
-36.99
|
-122.12
|
| Operating Income Ratio |
-1.02
|
-0.6
|
-44.59
|
-3.1
|
-7.64
|
-13.03
|
-11.07
|
-27.69
|
-37.26
|
-126.96
|
| Total Other Income/Expenses Net |
$13.40 M
|
$9.81 M
|
$1.58 M
|
$4.57 M
|
$2.63 M
|
$14.68 M
|
$12.94 M
|
$1.25 M
|
$542,000.00
|
$142,000.00
|
| Income Before Tax |
-$97.01 M
|
-$58.19 M
|
-$161.14 M
|
-$122.45 M
|
-$150.75 M
|
-$193.64 M
|
-$146.58 M
|
-$101.33 M
|
-$54.79 M
|
-$19.16 M
|
| Income Before Tax Ratio |
-0.9
|
-0.51
|
-44.16
|
-2.99
|
-7.51
|
-12.12
|
-10.17
|
-27.36
|
-36.89
|
-126.03
|
| Income Tax Expense |
$0.00
|
-$677,000.00
|
$681,000.00
|
-$204,000.00
|
-$841,000.00
|
-$14.14 M
|
$69,000.00
|
$708,000.00
|
$616,000.00
|
$44,000.00
|
| Net Income |
-$97.01 M
|
-$57.51 M
|
-$161.82 M
|
-$122.25 M
|
-$149.91 M
|
-$179.50 M
|
-$146.65 M
|
-$102.04 M
|
-$55.40 M
|
-$19.20 M
|
| Net Income Ratio |
-0.9
|
-0.51
|
-44.35
|
-2.98
|
-7.47
|
-11.23
|
-10.17
|
-27.55
|
-37.31
|
-126.32
|
| EPS |
-0.7 |
-0.54 |
-2.05 |
-2.36 |
-3.82 |
-5.3 |
-5.06 |
-3.85 |
-2.43 |
-1.83 |
| EPS Diluted |
-0.7 |
-0.54 |
-2.05 |
-2.36 |
-3.82 |
-5.3 |
-5.06 |
-3.85 |
-2.43 |
-1.83 |
| Weighted Average Shares Out |
$138.28 M
|
$106.10 M
|
$78.86 M
|
$51.83 M
|
$39.23 M
|
$33.87 M
|
$28.97 M
|
$26.51 M
|
$22.80 M
|
$10.50 M
|
| Weighted Average Shares Out Diluted |
$138.28 M
|
$106.10 M
|
$78.86 M
|
$51.83 M
|
$39.23 M
|
$33.87 M
|
$28.97 M
|
$26.51 M
|
$22.80 M
|
$10.50 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
